Nuo Yang
Guangxi Medical University
22 Papers
20 Citations
Nuo Yang is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Aptamer & Cancer. The author has an hindex of 11, co-authored 22 publications.
Chat about Author
Papers
An Efficient Cell-Targeting Drug Delivery System Based on Aptamer-Modified Mesoporous Silica Nanoparticles
Yang Yang,Weihua Zhao,Wenwen Tan,Zongqiang Lai,Dong Fang,Lei Jiang,Chuantian Zuo,Nuo Yang,Yongrong Lai +8 more
TL;DR: In this work, Sgc8-MSN/Dox showed sustained Dox release, and they targeted and efficiently killed CCRF-CEM human acute T lymphocyte leukemia cells, suggesting potential as a cancer therapy.
Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.
Zixi Hu,Jiaojiao Chen,Sufang Zhou,Nuo Yang,Siliang Duan,Zhenghua Zhang,Jing Su,Jian He,Zhiyong Zhang,Zhiyong Zhang,Xiaoling Lu,Yongxiang Zhao +11 more
TL;DR: Taking together, the data illustrate that the mIP-10 enhances the anti-tumor effect of DC/Tumor cell fusion vaccine by alleviating the immunosuppressive tumor environment.
66
Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells.
Juntao Tan,Nuo Yang,Zixi Hu,Jing Su,Jian-Hong Zhong,Yang Yang,Yating Yu,Jianmeng Zhu,Dabin Xue,Yingying Huang,Zongqiang Lai,Yong Huang,Xiaoling Lu,Yongxiang Zhao +13 more
TL;DR: Results showed that Sgc8-FSNPs detected leukemia cells with high sensitivity and specificity and changing the aptamer may allow the FSNPs to detect other types of cancer cells.
A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles.
Juntao Tan,Nuo Yang,Liping Zhong,Jie Tan,Zixi Hu,Qing Zhao,Wenlin Gong,Zhenghua Zhang,Rong Zheng,Zongqiang Lai,Yanmei Li,Chaofan Zhou,Guoqing Zhang,Duo Zheng,Ying Zhang,Siyu Wu,Xinglu Jiang,Jian-Hong Zhong,Yong Huang,Sufang Zhou,Yongxiang Zhao +20 more
TL;DR: Both in vitro experiments and in vivo animal studies clearly demonstrated that YQ 26-FSiNPs could achieve prominently high targeting efficiency and therapeutic effects via aptamer YQ26-mediated binding to endoglin (END) molecule.
32
A Graphene Oxide-Based Fluorescent Aptasensor for the Turn-on Detection of CCRF-CEM
Jie Tan,Zongqiang Lai,Liping Zhong,Zhenghua Zhang,Rong Zheng,Jing Su,Yong Huang,Panpan Huang,Hui Song,Nuo Yang,Sufang Zhou,Yongxiang Zhao +11 more
TL;DR: Graphene oxide-based fluorescent aptasensor based on graphene oxide-aptamer complex (GO-apt) can detect the number of CCRF-CEM cells in a wide range from 1 × 102 to 1‷ 107 cells/mL with a limit of detection (LOD) of 10 cells/mL.